Literature DB >> 6574829

Phenotype of human alpha-interferon producing leucocytes identified by monoclonal antibodies.

J Abb, H Abb, F Deinhardt.   

Abstract

Monoclonal antibodies with specificities for subsets of human leucocytes have been used for the characterization of alpha-interferon (alpha-IFN) producing cells. The production of alpha-IFN was demonstrated to be a function of Ia+ leucocytes. OKT3+ T lymphocytes, BA-1+ B lymphocytes and Leu 7+ natural killer (NK) cells did not contribute to the production of alpha-IFN. OKM1+ monocytes were essential for the production of alpha-IFN in response to bacterial products or leukaemia cells, but were not required for the synthesis of virus- or poly I:C-induced alpha-IFN. The results indicate that alpha-IFN producing cells represent a heterogenous population of cells of the myeloid lineage.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6574829      PMCID: PMC1535581     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  14 in total

1.  A monoclonal antibody with selective reactivity with functionally mature human thymocytes and all peripheral human T cells.

Authors:  E L Reinherz; P C Kung; G Goldstein; S F Schlossman
Journal:  J Immunol       Date:  1979-09       Impact factor: 5.422

2.  Effect of Corynebacterium parvum on human T-lymphocyte interferon production and T-lymphocyte proliferation in vitro.

Authors:  M Sugiyama; L B Epstein
Journal:  Cancer Res       Date:  1978-12       Impact factor: 12.701

3.  Rosette-forming human lymphoid cell lines. I. Establishment and evidence for origin of thymus-derived lymphocytes.

Authors:  J Minowada; T Onuma; G E Moore
Journal:  J Natl Cancer Inst       Date:  1972-09       Impact factor: 13.506

4.  Virus-induced interferon production by human macrophages.

Authors:  N J Roberts; R G Douglas; R M Simons; M E Diamond
Journal:  J Immunol       Date:  1979-07       Impact factor: 5.422

5.  Isolation and structure of a human fibroblast interferon gene.

Authors:  R Derynck; J Content; E DeClercq; G Volckaert; J Tavernier; R Devos; W Fiers
Journal:  Nature       Date:  1980-06-19       Impact factor: 49.962

6.  A monoclonal antibody reactive with human peripheral blood monocytes.

Authors:  J Breard; E L Reinherz; P C Kung; G Goldstein; S F Schlossman
Journal:  J Immunol       Date:  1980-04       Impact factor: 5.422

7.  Ia determinants on human T-cell subsets defined by monoclonal antibody. Activation stimuli required for expression.

Authors:  E L Reinherz; P C Kung; J M Pesando; J Ritz; G Goldstein; S F Schlossman
Journal:  J Exp Med       Date:  1979-12-01       Impact factor: 14.307

8.  Target cells for interferon production in human leukocytes stimulated by sendai virus.

Authors:  T Yamaguchi; K Handa; Y Shimizu; T Abo; K Kumagai
Journal:  J Immunol       Date:  1977-06       Impact factor: 5.422

9.  Human peripheral null lymphocytes. II. Producers of type-1 interferon upon stimulation with tumor cells, Herpes simplex virus and Corynebacterium parvum.

Authors:  H H Peter; H Dallügge; R Zawatzky; S Euler; W Leibold; H Kirchner
Journal:  Eur J Immunol       Date:  1980-07       Impact factor: 5.532

10.  Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. Identification of the anti-viral activity as interferon and characterization of the human effector lymphocyte subpopulation.

Authors:  G Trinchieri; D Santoli; R R Dee; B B Knowles
Journal:  J Exp Med       Date:  1978-05-01       Impact factor: 14.307

View more
  16 in total

Review 1.  Plasmacytoid dendritic cells: linking innate and adaptive immunity.

Authors:  Kelli McKenna; Anne-Sophie Beignon; Nina Bhardwaj
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

Review 2.  Plasmacytoid dendritic cells: in search of their niche in immune responses.

Authors:  Winfried Barchet; Amanda Blasius; Marina Cella; Marco Colonna
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

Review 3.  Plasmacytoid dendritic cells in antiviral immunity and autoimmunity.

Authors:  Fei Tang; Qiumei Du; Yong-Jun Liu
Journal:  Sci China Life Sci       Date:  2010-03-07       Impact factor: 6.038

4.  Resident plasmacytoid dendritic cells patrol vessels in the naïve limbus and conjunctiva.

Authors:  Arsia Jamali; Deshea L Harris; Tomas Blanco; Maria J Lopez; Pedram Hamrah
Journal:  Ocul Surf       Date:  2020-02-25       Impact factor: 5.033

5.  Analysis of plasmacytoid and myeloid dendritic cells in nasal epithelium.

Authors:  Evelyn Hartmann; Hendrik Graefe; Anne Hopert; Ralph Pries; Simon Rothenfusser; Hendrik Poeck; Brigitte Mack; Stefan Endres; Gunther Hartmann; Barbara Wollenberg
Journal:  Clin Vaccine Immunol       Date:  2006-08-23

6.  Infection with human T-lymphotropic virus type III and leukocyte interferon production in homosexual men.

Authors:  J Abb; H Piechowiak; R Zachoval; V Zachoval; F Deinhardt
Journal:  Eur J Clin Microbiol       Date:  1986-06       Impact factor: 3.267

7.  Immediate-early gene expression is sufficient for induction of natural killer cell-mediated lysis of herpes simplex virus type 1-infected fibroblasts.

Authors:  P Fitzgerald-Bocarsly; D M Howell; L Pettera; S Tehrani; C Lopez
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

8.  Natural killer-cell activity, interferon-alpha 2 production, and interleukin-2 production in cyclosporine-treated and conventionally immunosuppressed human allograft recipients.

Authors:  P J Guillou; G R Giles; C W Ramsden
Journal:  J Clin Immunol       Date:  1986-09       Impact factor: 8.317

9.  Age-related decline of human interferon alpha and interferon gamma production.

Authors:  J Abb; H Abb; F Deinhardt
Journal:  Blut       Date:  1984-05

10.  In-vitro and in-vivo studies on the induction of neopterin biosynthesis by cytokines, alloantigens and lipopolysaccharide (LPS).

Authors:  J Troppmair; K Nachbaur; M Herold; W Aulitzky; H Tilg; G Gastl; P Bieling; B Kotlan; R Flener; B Mull
Journal:  Clin Exp Immunol       Date:  1988-12       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.